5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide

C92H86F4N32O10 — CID 157338470

IUPAC5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide
SMILESCc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3C(C)C(=O)O)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3C(C)C(=O)O)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3C(C)C=O)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3[C@H](C)CO)n2)cc1-n1cnc(C2CC2)c1
InChIInChI=1S/2C23H21FN8O3.C23H23FN8O2.C23H21FN8O2/c2*1-12-8-16(24)15(9-19(12)31-10-18(25-11-31)14-6-7-14)22(33)27-20-5-3-4-17(26-20)21-28-29-30-32(21)13(2)23(34)35;2*1-13-8-17(24)16(9-20(13)31-10-19(25-12-31)15-6-7-15)23(34)27-21-5-3-4-18(26-21)22-28-29-30-32(22)14(2)11-33/h2*3-5,8-11,13-14H,6-7H2,1-2H3,(H,34,35)(H,26,27,33);3-5,8-10,12,14-15,33H,6-7,11H2,1-2H3,(H,26,27,34);3-5,8-12,14-15H,6-7H2,1-2H3,(H,26,27,34)/t;;14-;/m..1./s1
InChIKeyBGCRDUAZDBHGRU-PIXPJRFFSA-N
MW1875.91 g/mol
LogP12.60
Rot. Bonds28

About 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide

5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide (PubChem CID 157338470) has the molecular formula C92H86F4N32O10 and a molecular weight of 1875.91 g/mol. Its IUPAC name is 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide.

Molecular Properties

Compound Name5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide
PubChem CID157338470
Molecular FormulaC92H86F4N32O10
Molecular Weight1875.91 g/mol
Exact Mass1874.71
IUPAC Name5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide
SMILESCc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3C(C)C(=O)O)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3C(C)C(=O)O)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3C(C)C=O)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3[C@H](C)CO)n2)cc1-n1cnc(C2CC2)c1
InChIInChI=1S/2C23H21FN8O3.C23H23FN8O2.C23H21FN8O2/c2*1-12-8-16(24)15(9-19(12)31-10-18(25-11-31)14-6-7-14)22(33)27-20-5-3-4-17(26-20)21-28-29-30-32(21)13(2)23(34)35;2*1-13-8-17(24)16(9-20(13)31-10-19(25-12-31)15-6-7-15)23(34)27-21-5-3-4-18(26-21)22-28-29-30-32(22)14(2)11-33/h2*3-5,8-11,13-14H,6-7H2,1-2H3,(H,34,35)(H,26,27,33);3-5,8-10,12,14-15,33H,6-7,11H2,1-2H3,(H,26,27,34);3-5,8-12,14-15H,6-7H2,1-2H3,(H,26,27,34)/t;;14-;/m..1./s1
InChIKeyBGCRDUAZDBHGRU-PIXPJRFFSA-N
XLogP12.60
TPSA525.54 Ų
H-Bond Donors7
H-Bond Acceptors36
Rotatable Bonds28
Heavy Atoms138
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001875.91
LogP ≤ 512.60
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide?
The IUPAC name of 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide (CID 157338470) is 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide.
What is the SMILES notation for 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide?
The canonical SMILES for 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide is Cc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3C(C)C(=O)O)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3C(C)C(=O)O)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3C(C)C=O)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nnnn3[C@H](C)CO)n2)cc1-n1cnc(C2CC2)c1.
What is the InChIKey of 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide?
The InChIKey is BGCRDUAZDBHGRU-PIXPJRFFSA-N. The full InChI is InChI=1S/2C23H21FN8O3.C23H23FN8O2.C23H21FN8O2/c2*1-12-8-16(24)15(9-19(12)31-10-18(25-11-31)14-6-7-14)22(33)27-20-5-3-4-17(26-20)21-28-29-30-32(21)13(2)23(34)35;2*1-13-8-17(24)16(9-20(13)31-10-19(25-12-31)15-6-7-15)23(34)27-21-5-3-4-18(26-21)22-28-29-30-32(22)14(2)11-33/h2*3-5,8-11,13-14H,6-7H2,1-2H3,(H,34,35)(H,26,27,33);3-5,8-10,12,14-15,33H,6-7,11H2,1-2H3,(H,26,27,34);3-5,8-12,14-15H,6-7H2,1-2H3,(H,26,27,34)/t;;14-;/m..1./s1.
What are the key properties of 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide?
5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide has a molecular weight of 1875.91 g/mol, XLogP of 12.60, 28 rotatable bonds, 7 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;bis(2-[5-[6-[[5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoyl]amino]-2-pyridinyl]tetrazol-1-yl]propanoic acid);5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-[1-(1-oxopropan-2-yl)tetrazol-5-yl]-2-pyridinyl]benzamide is sourced from PubChem (CID 157338470), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).